LexaGene Holdings Inc.
Not enough financial coverage to compute a composite score for LXXGF. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.lexagene.com
LexaGene Holdings Inc. , a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
- CEO
- John F. Regan
- Employees
- 33
- HQ
- Beverly, MA, US
Price Chart
Growth & Income
- Revenue
- $75.31K · 29.57%
- Net Income
- $-10,620,000 · -6.56%
- EPS
- $-0.09 · 6.44%
- Op Income
- $-10,638,000
- FCF YoY
- -6.05%
Performance & Tape
- 52W High
- $0.22
- 52W Low
- $0.05
- 50D MA
- $0.15
- 200D MA
- $0.13
- Beta
- 2.04
- Avg Volume
- 223.59K
Get TickerSpark's AI analysis on LXXGF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LXXGF Coverage
We haven't published any research on LXXGF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LXXGF Report →